A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
Sanguine Biosciences
Study ID
NCT05794217
Status
Recruiting
Apply to this trial

Conditions

  • Rare Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Accepted

Interventions

  • This is a non-interventional study — BEHAVIORAL
    This is a non-interventional study

Study Details

To collect, preserve, and distribute annotated leukopak biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions. This protocol will be utilized to collect research grade products that are not meant for transfusion.

Key Dates

Start date
Sep 28, 2022
Status verified
Dec 2024
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
20,000 participants (estimated)

Primary Outcome Measure

Leukopak [ Time Frame: September 2022 and September 2024 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Sanguine BiosciencesWalthamMassachusetts02451
Sonia Lunar
[email protected]
855-836-4759
Timothy Triche, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Waltham, MA

By research site
Sanguine Biosciences· Waltham, MA

Related Studies